Related Experiment Video

Updated: May 27, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

[Coronary stents and non-cardiac surgery: current management strategies]

Paulo Carrasco1, Rodrigo López, Guillermo Lema

  • 1Departamento de Anestesiología, Pontificia Universidad Católica de Chile, Santiago, Chile. dr.paulocg@gmail.com

Revista Medica De Chile
|November 5, 2011
PubMed

Insights

Managing patients with coronary stents undergoing non-cardiac surgery requires careful consideration of dual antiplatelet therapy. High-risk patients need specialized care, including immediate reinitiation of therapy and aggressive treatment for stent thrombosis.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Surgical Management

Context:

  • Perioperative care for patients with coronary stents presents complex challenges.
  • Management of dual antiplatelet therapy (DAPT) is critical.
  • Coordination between anesthesiologists, surgeons, and cardiologists is essential.

Purpose:

  • To outline best practices for managing patients with coronary stents during non-cardiac surgery.
  • To guide decisions regarding dual antiplatelet therapy cessation and resumption.
  • To emphasize early recognition and aggressive treatment of stent thrombosis.

Summary:

  • Perioperative management hinges on surgery type, urgency, bleeding risk, stent type, time since placement, and stent thrombosis risk.
  • High-risk patients for stent thrombosis should undergo surgery at facilities with cardiac catheterization capabilities.
  • Postoperative monitoring and prompt reinitiation of antiplatelet therapy are crucial.

Impact:

  • Facilitates safer surgical outcomes for patients with coronary stents.
  • Reduces the incidence of perioperative stent thrombosis.
  • Promotes timely and effective intervention for acute stent thrombosis, improving patient prognosis.

More Related Videos

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...